deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT02303405

Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus

Comparing the Effects of Hydroxychloroquine (HCQ) to Pioglitazone in Type 2 Diabetic Patients Failing Maximal Doses of Metformin Plus a Sulfonylurea

Sponsor: Charles Drew University of Medicine and Science

Conditions Diabetes Mellitus Type 2 With Hyperglycemia
Interventions Hydroxychloroquine Pioglitazone
Updated 9 times since 2017 Last updated: Sep 23, 2022 Started: Nov 30, 2014 Primary completion: Nov 30, 2017 Completion: Nov 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Investigator decision

Other terminated trials from Charles Drew University of Medicine and Science

See all terminations from Charles Drew University of Medicine and Science

Listed as NCT02303405, this PHASE2 trial focuses on Diabetes Mellitus Type 2 With Hyperglycemia and remains terminated or withdrawn. Sponsored by Charles Drew University of Medicine and Science, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotTerminated~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE2

  5. Nov 2022 — Dec 2022 [monthly]

    Terminated PHASE2

▶ Show 4 earlier versions

  1. Jan 2021 — Nov 2022 [monthly]

    Terminated PHASE2

  2. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  3. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Charles Drew University of Medicine and Science
Data source: Charles Drew University of Medicine and Science

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations